Market Overview

UPDATE: JP Morgan Initiates LifePoint Hospitals at Overweight on Gains from Reform

Share:
Related LPNT
15 Biggest Mid-Day Losers For Friday
Stocks Hitting 52-Week Lows

JP Morgan initiated coverage on LifePoint Hospitals (NASDAQ: LPNT) with an Overweight rating and a $46 price target.

JP Morgan commented, "LifePoint should enjoy the highest EBITDA upside potential from reform-based coverage expansion. A combination of the company's geographic footprint, coupled with the managed care negotiating leverage of a sole community provider heading into exchange pricing discussions, should enable LifePoint to capture outsized gains compared to peers in our opinion. Our JP Morgan Healthcare Reform Model estimates that LifePoint has the potential to see ~13% EBITDA upside from reform relative to our baseline model, although a relative lack of financial leverage leaves relative EPS gains significant but more in line to peer average."

LifePoint Hospitals closed at $36.92 on Monday.

Latest Ratings for LPNT

DateFirmActionFromTo
Aug 2016Raymond JamesMaintainsOutperform
Aug 2016CitigroupMaintainsBuy
Aug 2016Morgan StanleyMaintainsEqual-weight

View More Analyst Ratings for LPNT
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (LPNT)

View Comments and Join the Discussion!